Expeditors International of Washington Full Year 2024 Earnings: Beats Expectations
Revenue: US$10.6b (up 14% from FY 2023).
Net income: US$810.1m (up 7.6% from FY 2023).
Profit margin: 7.6% (down from 8.1% in FY 2023). The decrease in margin was driven by higher expenses.
EPS: US$5.75 (up from US$5.05 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Revenue exceeded analyst estimates by 1.7%. Earnings per share (EPS) also surpassed analyst estimates by 4.4%.
Looking ahead, revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Logistics industry in the US.
Performance of the American Logistics industry.
The company's shares are up 5.0% from a week ago.
Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of Expeditors International of Washington's balance sheet and an in-depth analysis of the company's financial position.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
MRO acquires clinical data management platform Q-Centrix from TPG Growth
US-based clinical data exchange company MRO has acquired Q-Centrix, an enterprise clinical data management platform previously owned by TPG Growth. Q-Centrix is a comprehensive data management platform designed to reduce complexity, expedite decisions and advance clinical outcomes. MRO said the acquisition would enable hospitals and health systems to convert fragmented clinical data into actionable insights, expediting the exchange of clinical data across the sector. The deal is expected to create scalable value for healthcare providers, payers and life sciences, supporting more precise decision-making and broader clinical applications. MRO CEO Jason Brown said: 'At MRO, we believe there is tremendous untapped value in unlocking and leveraging clinical data that resides in fragmented, siloed systems today. 'Combining MRO's leading clinical data exchange solutions and Q-Centrix's clinical data management capabilities creates a category-defining, fit-for-purpose platform, enabling high fidelity, low latency acquisition, abstraction, curation and exchange of clinical data to power better patient care and reduce costs across the healthcare ecosystem.' The combined entity will provide services to more than 2,000 health systems and hospitals, as well as over 7,000 clinics and almost 250 payers. By enriching and curating clinical data, MRO and Q-Centrix aim to deliver scalable value, facilitating precise decision-making and wider clinical applications. Q-Centrix CEO Milton Silva-Craig said: 'MRO and Q-Centrix share a commitment to advancing the industry in service of our customers. 'That focus is fuelling the creation of a first-of-its-kind platform—seamlessly integrating systems and delivering structured, highly valuable data sets to support clinical care, operational performance, breakthrough research, and regulatory compliance. 'Purpose-built around our customers' most pressing needs, this is innovation where it matters most.' The acquisition is supported by healthcare technology investors such as private equity company Parthenon Capital, which has reaffirmed its support for MRO with a new investment. The parties have not disclosed the value of the deal. "MRO acquires clinical data management platform Q-Centrix from TPG Growth" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Currency Exchange International Second Quarter 2025 Earnings: EPS: US$0.43 (vs US$0.079 in 2Q 2024)
Revenue: US$15.9m (down 21% from 2Q 2024). Net income: US$2.67m (up 428% from 2Q 2024). Profit margin: 17% (up from 2.5% in 2Q 2024). EPS: US$0.43 (up from US$0.079 in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Looking ahead, revenue is expected to decline by 7.2% p.a. on average during the next 2 years, while revenues in the Consumer Finance industry in North America are expected to grow by 13%. Performance of the market in Canada. The company's shares are down 5.1% from a week ago. What about risks? Every company has them, and we've spotted 3 warning signs for Currency Exchange International you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Waaree Solar Americas secures 599MW solar module supply deal in US
Waaree Solar Americas, the US subsidiary of India's solar PV module manufacturer, Waaree Energies, has signed a 599MW solar module supply agreement with an undisclosed independent power producer in the US. The modules will be manufactured at Waaree's manufacturing facility in Brookshire, Texas, with delivery anticipated in 2026. The company has secured 1.2GW in new orders in the US during the first quarter (Q1) of 2025/26, due to increased demand from AI-driven data centre growth, infrastructure upgrades and industrial electrification. To meet this increasing demand, Waaree Energies is boosting its production capabilities with the construction of an additional 1.6GW solar module manufacturing unit at its Brookshire site. This expansion will take the company's total manufacturing capacity in the US to 3.2GW before the end of 2025. The move aims to strengthen Waaree's service offerings for utility-scale and commercial and industrial solar projects. Waaree Solar Americas president Sunil Rathi stated: "This agreement is a strong testament to Waaree's commitment to developing a robust, US-based clean energy ecosystem. "Our Brookshire facility is uniquely positioned to meet rising demand with high-quality, American-made modules, helping our partners deliver on ambitious energy targets while creating jobs and ensuring supply security. "This partnership reflects our shared vision to accelerate America's energy transition through dependable, high-performance solar technology. Backed by decades of manufacturing excellence in India, we're proud to support our US partners with scaleable solutions tailored to this evolving market." Waaree Solar Americas recently signed a 586MW solar module supply deal, with delivery scheduled for 2026 and 2027. The modules under the $176m deal will be manufactured at Waaree's facility in Brookshire, Texas. "Waaree Solar Americas secures 599MW solar module supply deal in US" was originally created and published by Power Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
